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| INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide, especially in developing countries. [1] [2] [3] Formation of HCC results from multiple risk factors, including HBV or HCV infection, cirrhosis, excessive alcohol consumption, and a variety of genetic factors. 4 Increasing evidences reveal that diabetes is associated with an increased HCC incidence and has been far more than HBV, HCV, or alcoholic liver disease. A study in Taiwan populations has reported that the incidence of HCC was twice higher in the diabetes patients group compared with the non-diabetes patients. 5 Similarly, HBEl-Serag research showed that the proportion of HCC patients with diabetes (43%) was significantly greater than non-cancer controls (19%). 6 However, the potential mechanism for the pathogenesis of HCC with diabetes is incompletely understood.
High glucose increases intracellular concentrations of UDPGlcNAc, resulting in increased global O-GlcNAcylation. 7 O-GlcNAc is an O-linked-β-N-acetylglucosamine moiety attached to the residue of serine or threonine on nuclear or cytoplasmic proteins. 8 The addition
of O-GlcNAc to proteins is catalysed by O-GlcNAc transferase (OGT), and its removal is catalysed by O-GlcNAcase (OGA). 9 OGlcNAcylation regulates such diverse cellular processes as nutrient sensing, cell cycle progression, transcription, translation, epigenetic regulations, and protein-protein interactions. [10] [11] [12] [13] O-GlcNAcylation is believed to play a role in a variety of signalling cascades that mediate glucose homoeostasis and stress responses.
14 Elevated O-GlcNAcylation has been described in different cancer types including breast, prostate, liver, colon, lung, and chronic lymphocytic leukaemia. [15] [16] [17] [18] [19] These studies indicate that high O-GlcNAcylation seems to be a general feature of cancer cells and contributes to tumorigenesis. In hepatoma, Zhu et al reported that O-GlcNAcylation was higher in cancer tissues compared to normal tissues. Moreover, O-GlcNAcylation was higher again in patients diagnosed a recurrence of hepatocarcinoma. 17 Considering that high glucose increases global O-GlcNAcylation, elucidating the role of O-GlcNAcylation in hepatoma progression helps to improving our understanding of the association between diabetes and HCC. However, the contribution of O-GlcNAcylation in hepatoma development remains largely unknown.
In this study, we investigated the roles of OGT in hepatoma development. We found that OGT was highly expressed in hepatocellular carcinoma. OGT activated stem-like cell potential of hepatoma cell through O-GlcNAcylation of eukaryotic initiation factor 4E. Eukaryotic initiation factor 4E, a key translation factor, bound to stem-related gene Sox2 5'-untranslated region. High glucose promoted stem-like cell potential of hepatoma cell through OGT-eIF4E axis. Our findings indicate that OGT promotes the stem-like cell potential of hepatoma cell through OGlcNAcylation of eIF4E, providing a mechanism of HCC development.
| MATERIALS AND METHODS

| Human tumour tissues
Hepatocarcinoma tissues and matching tumour adjacent normal tissues were obtained from the ZhongShan Hospital, Shanghai. The procedures related to human subjects were approved by the Ethics Committee of the Institutes of Biomedical Sciences, Fudan University. Experiments were undertaken with the understanding and written consent of each subject.
| Plasmids and transfection
PCRs were performed to amplify eIF4E cDNA and inserted eIF4E
cDNA into Lv-Flag vector with Flag tag at N-terminal region, HA tag at C-terminal region. eIF4E single mutant (T168A or T177A) and double mutant (T168, 177A) were constructed. The pCMV-OGT-myc plasmid was provided as described previously. 20 The pLKO.1-OGT shRNA plasmids were constructed. Transient transfection was performed fol- 
| Western blotting
Cell lysates were produced by 1x sample loading buffer, boiled for 
| Mapping of O-GlcNAc site using mass spectrometry
To map O-GlcNAc sites, Nano-LC-ESI-MS/MS was performed as previously described. 21 Overexpressed wild-type Flag-eIF4E proteins in HEK293T cells were purified using ANTI-FLAG M2 affinity gel (Sigma-Aldrich, A2220) and subjected to SDS-PAGE.
| RNA-ChIP assays
RNA-ChIP assays were performed using RNA ChIP-IT Kit (Activemotif, 5ʹ-GCAGATGGTCGTTTGGCTGAATA-3ʹ.
| Tissue microarray and immunohistochemistry
Tissue microarray was constructed and immunohistochemistry was carried out as described previously. 22, 23 The eIF4E and O-GlcNAcylation immunostaining intensities were semi-quantitatively scored as:
0, negative; 1, weak; 2, moderate; and 3, strong. All samples were anonymized and independently scored by two investigators. In case of disagreement, the slides were re-examined and a consensus was reached by the observers.
| sWGA-affinity purification
Cells and tissues were lysed with RIPA lysis buffer (150 mM NaCl, 50 mM Tris (pH = 7.4), 1 mM EDTA, 1% Nonidet P-40) and lysates were incubated with agarose-conjugated sWGA (Vector Laboratories, AL-1023S) for overnight at 4°C. For control of specificity, 50 mM GlcNAc (Sigma-Aldrich, A3286) was added. Precipitates were washed three times with lysis buffer and proteins were eluted by boiling in 1x SDS sample buffer. 
| Immunoprecipitation assays
| Tumorsphere assays
For spheroid assays, cells were digested to single-cell and seeded 
| Statistical analyses
Statistical analysis of the data was calculated by using two-tailed Student's t tests (*P < 0.05, **P < 0.01) on GraphPad Prism. All values included in figures represent mean ± SD Error bars represent SD. Data are representative of at least three independent experiments. Total O-GlcNAcmodified proteins were precipitated with succinylated wheat germ agglutinin (sWGA), a lectin binding specifically to O-GlcNAc. The precipitates were then analysed by western blotting for eIF4E. For control, monosaccharide inhibitor GlcNAc (N-Acetyl-D-glucosamine, 50 mM) was added during sWGA lectin-affinity purification. The specificity of the sWGA lectin is illustrated by effectively competing the lectin with GlcNAc. D, Paired HCC specimens lysates were subjected to sWGA-affinity purification and the precipitates were analysed by western blotting for eIF4E. β-actin expression was served as a loading control F I G U R E 4 eIF4E is O-GlcNAc-modified at Threonine 168 and Threonine 177. A, Flag-eIF4E was purified from HEK293T cells co-expressing with OGT by immunoprecipitated for western blotting (left panel) and coomassie blue staining (right panel). The arrow indicated Flag-tagged eIF4E. B, Flag-eIF4E was analysed by mass spectrometry. Mass spectrum of the doubly charged peptide IAIWT (GlcNAc T) ECENREAV (GlcNAc T) HIGRVYK showed O-GlcNAcylation at Thr168 and Thr177. The b and y type product ions were marked on the spectrum. C, The level of eIF4E protein in Huh7 cells transfected with plasmids expressing wild-type eIF4E or its O-GlcNAcylation site mutant were analysed by western blotting. β-actin expression was served as a loading control. D, The levels of exogenous eIF4E mRNA in Huh7 cells transfected with plasmids expressing wild-type eIF4E or its O-GlcNAcylation site mutant were analysed by quantitative reverse transcription PCR and normalized against β-actin. Error bars represent ±SD of triplicate experiments. The two-tailed Student's t test was used. n.s, no significance. E, Huh7 cells were transfected with plasmids expressing wild-type eIF4E or its O-GlcNAcylation site mutant before CHX (10 μg/mL) was added and treated for indicated durations. Levels of exogenous eIF4E were determined by western blotting and normalized against β-actin. Meanwhile, some reports have showed that stem-like potential proteins, such as Sox2, OCT4, and KLF4, which can augment stem-cell function. And these proteins can be used as stemness-related markers. [26] [27] [28] [29] The expression of stem-like cell potential proteins (Sox2, OCT4 and KLF4) were also reduced in Huh7 cells with OGT knockdown ( Figure 6J ). Together, these data suggest that OGT promotes cell proliferation and activates stem-like cell potential in hepatocarcinoma.
| eIF4E is O-GlcNAcylated in hepatoma
We next aimed to explore the mechanisms underlying OGT promotes stem-like cell potential in hepatocarcinoma. Previous study reported that O-GlcNAc modification of ribosomal subunits contributed to the translational machinery. 12 Of numerous eukaryotic initiation factors in translational machinery, eIF4E is a key player in the regulation of translation initiation and is required for the recruitment of specific mRNAs to the ribosome. 30 eIF4E has been reported to regulate the self-renewal of glioma-initiating cell. 31 These findings promoted us to investigate whether eIF4E was OGlcNAcylated. First, we examined whether exogenous eIF4E could be O-GlcNAcylated. Flag-tagged eIF4E purified from HEK293T cells was examined by immunoblotting using the anti-O-GlcNAc antibody (RL2). Western blot assay showed that exogenous eIF4E could be O-GlcNAcylated ( Figure 3A) . Next, we examined whether OGlcNAcylation of eIF4E also occurs in hepatoma cell. Total OGlcNAc modified protein were immunoprecipitated from cell extracts of Huh7 and PLC/PRF/5 cells using RL2 antibody. Endogenous eIF4E was successfully detected in precipitates ( Figure 3B ).
Accordingly, exogenous eIF4E has been O-GlcNAc modified in
Huh7 and PLC/PRF/5 cells using succinylated wheat germ agglutinin (sWGA) for affinity purification ( Figure 3C ). To further determine whether eIF4E was O-GlcNAcylated in the liver cancer samples, we used sWGA for affinity purification of hepatocellular carcinoma and adjacent normal tissues lysates. The precipitates were successfully probed with an antibody against eIF4E ( Figure 3D ). Thus, eIF4E is O-GlcNAcylated in hepatoma.
| Mutation of eIF4E O-GlcNAc sites at threonine 168 and threonine 177 reduces its protein stability
To determine the location of the O-GlcNAc site(s) on eIF4E by mass spectrometry analysis, Flag-eIF4E was purified from HEK293T cells F I G U R E 5 OGT knockdown reduces eIF4E protein expression and higher expression of eIF4E indicates a poor prognosis in HCC patients. A, The protein level of eIF4E was analysed by western blotting in Huh7 infected with control shRNA, OGT shRNA1 and OGT shRNA2 lentivirus. β-actin expression was served as a loading control. B, OGT values were calculated from images in A. Data represent mean ± SD of at least three independent experiments. **P < 0.01. C, eIF4E values were calculated from images in A. Data represent mean ± SD of at least three independent experiments. *P < 0.05; **P < 0.01. D, The protein level of eIF4E was analysed by western blotting in PLC/PRF/5 cells infected with control shRNA, OGT shRNA1, and OGT shRNA2 lentivirus. β-actin expression was served as a loading control. E, OGT values were calculated from images in D. Data represent mean ± SD of at least three independent experiments. **P < 0.01. F, eIF4E values were calculated from images in D. Data represent mean ± SD of at least three independent experiments. **P < 0.01; n.s, no significance. G, The protein level of eIF4A and eIF4G were analysed by western blotting in Huh7 and PLC/PRF/5 cells infected with control shRNA or OGT shRNA2 lentivirus. β-actin expression was served as a loading control. H, eIF4G, and eIF4A values were calculated from images in G. Data represent mean ± SD of at least three independent experiments. n.s, no significance. I, Representative immunohistochemical staining of eIF4E in liver cancer tissues and peri-tumour liver tissues. J, Quantitative analysis of liver cancer tissue microarrays showed that the expression of eIF4E was higher in liver cancer tissues than in normal liver tissues (P < 
| Knockdown of OGT reduces eIF4E expression and high expression of eIF4E predicts poor prognosis of HCC
The finding that O-GlcNAcylation participated in eIF4E stability motivated us to investigate whether OGT regulated eIF4E protein F I G U R E 6 Knockdown OGT inhibits proliferation and tumorsphere formation of hepatoma cell through reducing eIF4E expression. A, Huh7 and PLC/PRF/5 cells were infected with control shRNA, OGT shRNA2 alone, or with wild-type eIF4E lentivirus. The cell lysates were harvested for western blotting analysis using indicated antibodies. β-actin expression was served as a loading control. Error bars represent ±SD of triplicate experiments. **P < 0.01; n.s, no significance. K, Huh7 cells were collected and subjected to immunoprecipitation with antibody against eIF4E or normal mouse IgG. Total RNAs were purified from immunocomplexes and subjected to RT-PCR to measure Sox2, OCT4, and KLF4 mRNAs associated with eIF4E Univariate analysis was calculated by the Kaplan-Meier method (log-rank test). Multivariate analysis was done using the Cox multivariate proportional hazard regression model with stepwise manner (forward, likelihood ratio). CI, confidential interval; HR, hazard ratio; NA, not adopted; NS, not significant. on OCT4 at T228 is important to maintain embryonic stem cell selfrenewal. 38 Our data showed that OGT activated stem-like cell potential in hepatocarcinoma. To our knowledge, this is the first report that O-GlcNAcylation contributes to stem-like cell potential of hepatoma cell. However, the difference of O-GlcNAcylation in normal stem cell and cancer stem cell should be further investigated.
OGT activated stem-like cell potential in hepatoma cell partly through up-regulation of eIF4E expression. The eukaryotic translation initiation factor 4E is a key regulator of protein synthesis, which is generally the rate-limiting factor recruits mRNAs to eIF4F. 30 Uncontrolled of eIF4E activity or expression in various cancers stimulates cellular proliferation and malignant transformation. 39, 40 Thus, eIF4E has been considered as a therapeutic target in cancer. Previous studies indicate that eIF4E regulates function of common tumour cells. 40 Here, we found that ectopic expression of eIF4E increased the diameter and number of tumorsphere and increased the expression of stem-like cell potential proteins (Sox2, OCT4). Furthermore, 5ʹ-UTR of Sox2 mRNA but not OCT4 mRNA, was tightly bound to eIF4E by RNA-ChIP assay.
The literature suggest that cellular mRNAs most sensitive to alterations in eIF4E availability and eIF4F complex formation. In tumours, elevated eIF4E function selectively and disproportionately increases translation of weak mRNAs. These mRNAs with G/C-rich 5ʹ-UTR had encoded potent growth, and survival factors notoriously involved in malignancy. 40 Accordingly, we found that 5ʹ-UTR of Sox2 had rich G/C bases compared to 5ʹ-UTR of OCT4. Our data indicate that eIF4E regulates the stem-like cell potential of hepatoma cell, providing a new mechanism that eIF4E promotes cancer development.
Our data also provide evidence that O-GlcNAcylation increases the stability of eIF4E protein. The activity or expression of eIF4E is controlled by its binding proteins and by upstream signalling pathways. For example, phosphorylation of eIF4E on S209 by MNK1/2, released eIF4E from eIF4E-binding proteins (4EBP1), resulting in the activation of eIF4E. 41 Phosphorylation of eIF4E on S209 is elevated in human cancer and is associated with tumour aggressiveness and poor patient outcome. 42 In addition, eIF4E is ubiquitinated at Lys159, suggesting the proteasome-dependent proteolysis of eIF4E. 43 Increasing researches suggest OGT participates in protein stability. 32, 33 In this study, O-GlcNAcylation of eIF4E at Thr168 or Thr177 protected it against proteasomal degradation and increased eIF4E protein stability. However, mutation at Thr168 and Thr177 did not completely abolish eIF4E O-GlcNAcylation, indicated that other O-GlcNAc site(s) was not detected by MS Other O-GlcNAcylation site(s) of eIF4E needs to be further identified. Even so, eIF4E OGlcNAcylation regulates its protein stability, proving a linking between high glucose and cell proliferation.
In summary, we have described a novel role for the metabolic sensor OGT in the growth and stem-like cell potential of hepatoma cells. OGT activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E. These results provide a mechanism of HCC development. Furthermore, our findings that OGT-eIF4E axis contributes to high glucose activating hepatoma cell stem-like cell potential might provide a cue of the pathogenesis of HCC with diabetes.
